You have 9 free searches left this month | for more free features.

safety analysis

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Blind, Self Controlled, Multicenter Clinical Trial on

Recruiting
  • CHD - Coronary Heart Disease
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
    Aug 9, 2021

    Chronic Kidney Disease Trial in Brooklyn (Zibotentan (Treatment A), Dapagliflozin (Treatment A), Zibotentan/Dapagliflozin -

    Completed
    • Chronic Kidney Disease
    • Zibotentan (Treatment A)
    • +3 more
    • Brooklyn, Maryland
      Research Site
    Nov 22, 2021

    Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)

    Not yet recruiting
    • Solid Tumor
    • +5 more
    • AZD1390
    • Stereotactic Body Radiotherapy
    • New York, New York
    • +1 more
    Jan 12, 2023

    Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

    Completed
    • Unspecified Adult Solid Tumor, Protocol Specific
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Effectiveness in Cystic Fibrosis

    Active, not recruiting
    • Cystic Fibrosis
    • Contraception
      • Birmingham, Alabama
      • +9 more
      May 11, 2022

      Postmenopausal Period, Vaginal Atrophy, Vaginal Prolapse Trial in Nizhny Novgorod (device, drug, diagnostic test, other)

      Recruiting
      • Postmenopausal Period
      • +2 more
      • Laser Treatment
      • +14 more
      • Nizhny Novgorod, Russian Federation
        State-Funded Healthcare Institution of the Nizhny Novgorod regio
      Nov 8, 2022

      Chordoma Trial in Baltimore, New York (other, biological, radiation)

      Active, not recruiting
      • Chordoma
      • Laboratory Biomarker Analysis
      • +2 more
      • Baltimore, Maryland
      • +1 more
      Oct 3, 2022

      Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in

      Active, not recruiting
      • Bone Marrow Transplantation Recipient
      • +2 more
      • Eltrombopag Olamine
      • Laboratory Biomarker Analysis
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 9, 2022

      Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

      Active, not recruiting
      • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
      • Plasma Cell Myeloma
      • Incomplete Freund's Adjuvant
      • +4 more
      • Buffalo, New York
      • +1 more
      Dec 12, 2022

      Retrospective Follow-up of BIOLUX P-I/-II

      Completed
      • Overall Mortality
      • Passeo-18
      • Passeo-18 Lux
      • Graz, Austria
      • +7 more
      Aug 4, 2021

      Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban

      Active, not recruiting
      • Treatment of Venous Thromboembolism in Cancer Patients
      • +2 more
      • Wuppertal, Germany
        Bayer
      Jul 25, 2022

      Prostate Cancer, Focal Laser Ablation, Transperineal Laser Ablation Trial in Amsterdam (Echolaser X4 system)

      Completed
      • Prostate Cancer
      • +2 more
      • Echolaser X4 system
      • Amsterdam, Noord-Holland, Netherlands
        Academic Medical Center
      Oct 15, 2021

      Solid Tumor Trial in Duarte (RNR inhibitor COH29, laboratory biomarker analysis, pharmacological study)

      Suspended
      • Unspecified Adult Solid Tumor, Protocol Specific
      • RNR inhibitor COH29
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Mar 17, 2022

      Acute Ischemic Stroke Trial in Austria (Cerebrolysin)

      Recruiting
      • Acute Ischemic Stroke
      • Amstetten, Austria
      • +7 more
      Mar 28, 2022

      Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem

      Completed
      • Metastatic Malignant Neoplasm in the Brain
      • +11 more
      • Laboratory Biomarker Analysis
      • siRNA-transfected Peripheral Blood Mononuclear Cells APN401
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      Aug 5, 2022

      Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,

      Completed
      • Metastatic Carcinoma in the Liver
      • +4 more
      • Durvalumab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 30, 2023

      Analgesia in ÖAMTC Helicopter Emergency Service in Austria

      Completed
      • Field Physician Care
      • +7 more
      • analgesics
      • hypnotics
      • Innsbruck, Austria
        General and Surgical Critical Care Medicine, Medical University
      Sep 7, 2021

      Latent Tuberculosis Infection Prophylaxis Treatment

      Recruiting
      • Adverse Reaction to Drug
      • 3HP
      • Taipei, Taiwan
        Institutional Review Board Chang Gung Medical Foundation
      Dec 4, 2020

      Lung Cancer, Lung Metastases Trial in United States (Nintedanib, Prednisone, Placebo)

      Active, not recruiting
      • Lung Cancer
      • Lung Metastases
      • Boston, Massachusetts
      • +11 more
      Jul 19, 2022

      Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

      Active, not recruiting
      • Fallopian Tube Clear Cell Adenocarcinoma
      • +22 more
      • Laboratory Biomarker Analysis
      • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
      • Rochester, Minnesota
        Mayo Clinic
      Oct 7, 2022

      EASINESS-TRIAL - Enhancing Safety in Epilepsy Surgery

      Recruiting
      • Epilepsy, Temporal Lobe
      • Amygdalo-Hippocampal Epilepsy
      • Mesial temporal lobe epilepsy surgery
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Jun 26, 2021

      Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,

      Recruiting
      • Colorectal Cancer
      • +3 more
      • Glutaminase Inhibitor CB-839
      • +5 more
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Mar 29, 2022

      AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte

      Active, not recruiting
      • AIDS-related Non-Hodgkin Lymphoma
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Feb 17, 2022

      Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell

      Active, not recruiting
      • Anaplastic Large Cell Lymphoma
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Duarte, California
      • +1 more
      Jul 26, 2022

      EchoNavigator System Release II During Structural Heart

      Unknown status
      • Cardiac Imaging Techniques
      • Data analysis
      • Dusseldorf, Germany
        Division of Cardiology, Pulmonary Disease and Vascular Medicine
      Feb 15, 2021